Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal Cancer

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Xie, Zijun ^a,b   Chen, Gang ^c   Zhang, Xuchao ^a   Li, Dongfeng ^d   Huang, Jian ^e   Yang, Cuiqin ^c   Zhang, Pingyong ^e   Qin, Yuxuan ^a   Duan, Yifan ^a   Gong, Bo ^a   Li, Zijun ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c Department of Thoracic Surgery ^*  (China)

^d Research Center of Medical Sciences   (China)

^e Physical Examination Center of East Ward   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 10B; MICRORNA 144; MICRORNA 21; MICRORNA 451; MICRORNA 486 5P; MICRORNA 634; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; HUMAN; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SUPERNATANT; UPREGULATION; VALIDATION PROCESS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SALIVA; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84875654001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057502     Document Type: Article

References (59)

1. Enzinger PC, Mayer RJ, (2003) Esophageal cancer. N Engl J Med 349: 2241-2252.
2. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Hongo M, Nagasaki Y, Shoji T, (2009) Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24: 729-735.
4. Sarah B Umar, David E Fleischer, (2008) Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 5: 517-526.
5. Li XY, Guo YB, Su M, Cheng L, Lu ZH, et al. (2011) Association of mitochondrial haplogroup D and risk of esophageal cancer in Taihang Mountain and Chaoshan areas in China. Mitochondrion 11: 27-32.
6. Kim T, Grobmyer SR, Smith R, Ben-David K, Ang D, et al. (2011) Esophageal cancer - the five year survivors. J Surg Oncol 103: 179-183.
7. Daly JM, Fry WA, Little AG, Winchester DP, McKee RF, et al. (2000) Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 190: 562-572, 572-573.
8. Croce C, (2012) Introduction to the role of microRNAs in cancer diagnosis, prognosis, and treatment. Cancer J 18: 213-214.
9. Matsushima K, Isomoto H, Kohno S, Nakao K, (2010) MicroRNAs and esophageal squamous cell carcinoma. Digestion 82: 138-144.
10. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, et al. (2011) Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 105: 104-111.
11. Lee YH, Wong DT, (2009) Saliva: an emerging biofluid for early detection of diseases. Am J Dent 22: 241-248.
12. Taylor DD, Gercel-Taylor C, (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21.
13. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH, (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46.
14. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, et al. (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56: 1733-1741.
15. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, et al. (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15: 5473-5477.
16. Wiklund ED, Gao S, Hulf T, Sibbritt T, Nair S, et al. (2011) MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS One 6: e27840.
17. Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of Malignant Tumors, 7th edn. Wiley-Liss: New York.
18. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, et al. (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16: 34-38.
19. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, et al. (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16: 34-38.
20. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A, (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840.
21. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
22. Akobeng AK, (2007) Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 96: 644-647.
23. Hanley JA, McNeil BJ, (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843.
24. Iguchi H, Kosaka N, Ochiya T, (2010) Secretory microRNAs as a versatile communication tool. Commun Integr Biol 3: 478-481.
25. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, et al. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452.
26. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
27. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
28. Li Y, Jiang Z, Xu L, Yao H, Guo J, et al. (2011) Stability analysis of liver cancer-related microRNAs. Acta Biochim Biophys Sin (Shanghai) 43: 69-78.
29. Schipper RG, Silletti E, Vingerhoeds MH, (2007) Saliva as research material: biochemical, physicochemical and practical aspects. Arch Oral Biol 52: 1114-1135.
30. Li Y, Elashoff D, Oh M, Sinha U, St JM, et al. (2006) Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 24: 1754-1760.
31. Mbulaiteye SM, Walters M, Engels EA, Bakaki PM, Ndugwa CM, et al. (2006) High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J Infect Dis 193: 422-426.
32. Streckfus C, Bigler L, Dellinger T, Pfeifer M, Rose A, et al. (1999) CA 15-3 and c-erbB-2 presence in the saliva of women. Clin Oral Investig 3: 138-143.
33. Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, et al. (2000) The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 6: 2363-2370.
34. Streckfus C, Bigler L, Dellinger T, Dai X, Cox WJ, et al. (2001) Reliability assessment of soluble c-erbB-2 concentrations in the saliva of healthy women and men. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 174-179.
35. Patel RS, Jakymiw A, Yao B, Pauley BA, Carcamo WC, et al. (2011) High resolution of microRNA signatures in human whole saliva. Arch Oral Biol 56: 1506-1513.
36. Biagioni F, Bossel BN, Fontemaggi G, Canu V, Mori F, et al. (2012) miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. EMBO Mol Med 4: 1214-1229.
37. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS, (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28: 3526-3536.
38. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, et al. (2009) MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49: 1571-1582.
39. Zen K, Zhang CY, (2012) Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32: 326-348.
40. Rossing M, Borup R, Henao R, Winther O, Vikesaa J, et al. (2012) Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. J Mol Endocrinol 48: 11-23.
41. Sureban SM, May R, Mondalek FG, Qu D, Ponnurangam S, et al. (2011) Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J Nanobiotechnology 9: 40.
42. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, et al. (2012) Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer 106: 740-747.
43. Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, et al. (2011) MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 17: 3976-3985.
44. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, et al. (2009) microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 15: 2281-2290.
45. Wang T, Zang WQ, Li M, Wang N, Zheng YL, et al. (2012) Effect of miR-451 on the Biological Behavior of the Esophageal Carcinoma Cell Line EC9706. Dig Dis Sci.
46. Zhang X, Wang X, Zhu H, Zhu C, Wang Y, et al. (2010) Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol 49: 841-850.
47. Wang X, Zhu H, Zhang X, Liu Y, Chen J, et al. (2012) Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res 94: 379-390.
48. Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, et al. (2010) The miR-144/451 locus is required for erythroid homeostasis. J Exp Med 207: 1351-1358.
49. Rasmussen KD, O'Carroll D, (2011) The miR-144/451eGFP allele, a novel tool for resolving the erythroid potential of hematopoietic precursors. Blood 118: 2988-2992.
50. Bonci D, (2010) MicroRNA-21 as therapeutic target in cancer and cardiovascular disease. Recent Pat Cardiovasc Drug Discov 5: 156-161.
51. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, et al. (2008) MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 135: 255-260.
52. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ, (2005) Increasing incidence of Barrett's oesophagus in the general population. Gut 54: 1062-1066.
53. Smith CM, Watson DI, Michael MZ, Hussey DJ, (2010) MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol 16: 531-537.
54. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, et al. (2008) Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68: 26-33.
55. Lambert R, Hainaut P, (2007) Esophageal cancer: cases and causes (part I). Endoscopy 39: 550-555.
56. Lin J, Zeng R, Cao W, Luo R, Chen J, et al. (2011) Hot beverage and food intake and esophageal cancer in southern China. Asian Pac J Cancer Prev 12: 2189-2192.
57. Xu XC, (2009) Risk factors and gene expression in esophageal cancer. Methods Mol Biol 471: 335-360.
58. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, et al. (2008) Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 67: 394-398.
59. Wang D, Su M, Tian D, Liang S, Zhang J, (2012) Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China. Cancer Epidemiol 36: 276-282.